drugset / Trial / NCT05331768

Comparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin Therapy

NCT05331768

Completed 109 enrolled Mexican Social Security Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

In the Western world, liver cirrhosis is a significant issue. Acute variceal bleeding (AVB) is a considerable complication of cirrhosis associated with high mortality. Still, the combination of endoscopic variceal ligation and terlipressin-like treatment decreases the risks of rebleeding and mortality. This therapy with terlipressin usually was used for 72 hours. However, there are some studies demostrating that using terlipressin for 24 hours could control variceal bleeding with fewer side effects.

Timeline

Start
2021-01-01
Primary completion
2021-09-30
Completion
2021-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 2 mg Intravenous

Indications